Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (73 total)
-
Creator: Jones, Rachael M., Susan C. Bleasdale, Dayana Maita, and Lisa M. Brosseau, for the C. D. C. Prevention Epicenters Program.
Subject: Infection Control
Item Type: Publication
Date Last Updated: 2020-01
Description: Personal protective equipment (PPE) is a primary strategy to protect health care personnel (HCP) from infectious diseases. When transmission-based PPE ensembles are not appropriate, HCP must recognize the transmission pathway of the disease and…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: Santarpia JL, Herrera VL, Rivera DN, Ratnesar-Shumate S, Reid SP, Ackerman DN, Denton PW, Martens JWS, Fang Y, Conoan N, Callahan MV, Lawler JV, Brett-Major DM, Lowe JJ.
Subject: Infection Control
Item Type: Publication
Date Last Updated: 2021-08-18
Description: Aerosol transmission of COVID-19 is the subject of ongoing policy debate. Characterizing aerosol produced by people with COVID-19 is critical to understanding the role of aerosols in transmission. -
Creator: WHO
Subject: General
Item Type: Hyperlink
Date Last Updated: 2021-08-07
Description: This WHO fact sheet covers Marburg virus disease: Key facts Transmission Symptoms of Marburg virus disease Diagnosis Treatment and vaccines Marburg virus in animals Prevention and control Controlling infection in healthcare settings Marburg viral… -
Creator: NETEC
Subject: Infection Control
Item Type: Guide
Date Last Updated: 2021-07-19
Description: NETEC recommends the “Identify, Isolate, and Inform” strategy. In this article, we provide a quick list of transmission precautions, PPE, waste, and other medical countermeasures. -
Creator: Daniel, William, Marc Nivet, John Warner, and Daniel K. Podolsky.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-05-20
Description: Emergency use authorizations for two messenger RNA (mRNA) vaccines — the BNT162b2 vaccine (Pfizer–BioNTech) and the mRNA-1273 vaccine (Moderna) — marked important milestones in efforts to respond to the coronavirus disease 2019 (Covid-19) pandemic.…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: CDC
Subject: Waste Management
Item Type: Hyperlink
Date Last Updated: 2023-04-20
Description: FAQs on Interim Guidance for Managers and Workers Handling Untreated Sewage from Suspected or Confirmed Individuals with Ebola in the U.S. | Cleaning and Decontamination | Public Health Planners | Ebola (Ebola Virus Disease) | CDC -
Creator: CDC
Subject: Waste Management
Item Type: Hyperlink
Date Last Updated: 2023-04-20
Description: Who this is for: Workers who handle untreated sewage that comes from hospitals, medical facilities, and other facilities with confirmed individuals with Ebola. What this is for: To provide recommendations for workers on the types of personal… -
Creator: Keehner, Jocelyn, Lucy E. Horton, Michael A. Pfeffer, Christopher A. Longhurst, Robert T. Schooley, Judith S. Currier, Shira R. Abeles, and Francesca J. Torriani.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-03-23
Description: Data from phase 3 clinical trials of messenger RNA (mRNA) vaccines through November 2020 showed 94.1% efficacy for the prevention of symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at 14 days after the second dose…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: Benenson, Shmuel, Yonatan Oster, Matan J. Cohen, and Ran Nir-Paz.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-03-23
Description: The surge of coronavirus disease 2019 (Covid-19) around the world and the need for urgent and intensive medical care have weighed heavily on health care systems and hospitals.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: the Oxford University Hospitals Staff Testing Group
Subject: Research
Item Type: Publication
Date Last Updated: 2021-02-11
Description: The relationship between the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains unclear.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.